2024 SPEAKERS

Michael Chisamore

Executive Director, Clinical Development

Merck & Co

Raj Ganesan

Executive Director, Oncology

Amgen Inc.

Yuanming Xu

Associate Director - Translational Oncology Lead

Pfizer

Angelica Loskog

CEO

Lokon Pharma AB

Deb Kientop

Vice President, Clinical Operations

DEKA Biosciences

Francesca Barone

Chief Scientific Officer

Candel Therapeutics

Geoff Stone

Director, Biologics

Exelixis Inc.

Howard Kaufman

President & Chief Executive Officer

Ankyra Therapeutics

John Hoerter

Senior Principal Scientist

Novartis AG

John Mumm

Chief Executive Officer & Co- Founder

DEKA Biosciences

Longli Zhou

Lead Research Analyst

Hanson Wade

Matt Giacalone

Chief Executive Officer

Vaxiion Therapeutics

Oliver Van Oekelen

Physician-Scientist

Icahn School of Medicine, Mount Sinai

Praveen Bommareddy

Senior Director - Translational Research

Replimune

Stefan Scherer

Chief Executive Officer

3T Biosciences

Talia Biran

President

Oncolys BioPharma Inc.

Tony Arulanandam

CEO and Founder

Synaptimmune Therapeutics

Victor Cervera

Vice President - Business Development

TILT Biotherapeutics Ltd.

Wayne Carter

President and CEO

TVAX Biomedical LLC

William Jia

Chief Scientific Officer

Virogin Biotech Ltd

FULL EVENT GUIDE
REGISTER
PARTNER